Outcome Of Board Meeting Dated August 14, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Aimco Pesticides approved the unaudited financial results for Q1FY26 (quarter ended June 30, 2025). Standalone revenue from operations rose to Rs 4,752.12 lakhs from Rs 3,934.52 lakhs in Q1FY25, a growth of about 20.8%. However, the company reported a widened standalone net loss of Rs 177.66 lakhs versus Rs 149.93 lakhs in the year-ago quarter, as total expenses grew faster than revenue. On a consolidated basis, revenue grew to Rs 4,798.11 lakhs (~22% YoY) with a slightly improved loss of Rs 149.78 lakhs. The Board also approved the Directors' Report and notice for the 38th AGM scheduled for September 25, 2025, and reappointed Mrs. Elizabeth Chandraprakash Shrivastava as Executive Whole-Time Director for three years. The statutory auditor, M/s CNK & Associates LLP, issued an unmodified limited review report on the results.
Positive top-line growth of over 20% YoY signals improving demand, but the widening losses and growing expense base raise concerns about margin pressure and the company's path to profitability. Shareholders should watch for cost rationalisation and whether revenue momentum translates into better margins in upcoming quarters. The director reappointment and AGM schedule are routine governance items with no immediate material impact.